Meningococcal ACWY conjugate vaccine immunogenicity in adolescents with primary or secondary immune deficiencies, a prospective observational cohort study.
Milou OhmJoeri W van StraalenGerrie de Joode-SminkJoris van MontfransMarije BartelsJoanne G van WildenbeestCaroline A LindemansRoos Aw WenninkJoke H de BoerElisabeth Am SandersFrans M Verduyn-LunelGuy Am BerbersNico M WulffraatMarc H A JansenPublished in: Pediatric rheumatology online journal (2023)
The MenACWY conjugate vaccine was less immunogenic in adolescent patients with primary or secondary immunodeficiency compared to healthy controls, urging the need for further surveillance of these patients and supporting considerations for booster MenACWY conjugate vaccinations in these patient groups.